Transient hypothyroxinanaemia
Conditions
Interventions
Product Name: Sodium iodide Injection BP 2004
Product Code: non-proprietary
Pharmaceutical Form: Oral solution
INN or Proposed INN: Sodium iodide
CAS Number: 7681-82-5
Concentration unit: µg/ml microg
Sponsors
University of Dundee
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Infants born ==65 years) no F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: Infants born > 30 weeks gestation. Mothers and infants will be excluded from the study if they are known to be viral hepatitis/HIV positive, have problmes giving consent because of mental illness or communication difficulties. Infants with serious congential anomaly will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: 1. We aim to determine whether enteral supplementation with iodine is effective in promoting a positive iodine balance in extreme preterm infants who are parenterally fed. 2. To determine the efficacy of the oral versus the nasogastric route of iodine supplementation.;Secondary Objective: None;Primary end point(s): Iodine balance at postnatal days 7, 14, 28 | — |
Countries
United Kingdom
Outcome results
None listed